Publikationsverzeichnis_seemueller_111213

Ausgewählte Artikel (aus über 65 Originalarbeiten):
Seemüller F
, Möller HJ, Dittmann S, Musil R. Is the efficacy of psychopharmacological drugs comparable to the
efficacy of general medicine medication? BMC Med. 2012 Feb 15;10:17.
Seemüller F, Lewitzka U, Bauer M, Meyer S, Musil R, Schennach R, Riedel M, Doucette S, Möller HJ. The
Relationship of Akathisia with Treatment Emergent Suicidality among Patients with First-Episode Schizophrenia
Treated with Haloperidol or Risperidone. Pharmacopsychiatry. 2012 May 21. [Epub ahead of print]

Seemüller F
, Riedel M, Obermeier M, Schennach-Wolff R, Spellmann I, Meyer S, Bauer M, Adli M, Kronmüller K,
Ising M, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Möller HJ. The validity of self-rated psychotic
symptoms in depressed inpatients. Eur Psychiatry. 2011 Mar 8. [Epub ahead of print]

Seemüller F, Möller HJ, Obermeier M, Adli M, Bauer M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W,
Heuser I, Zeiler J, Gaebel W, Schennach-Wolff R, Henkel V, Riedel M. Do efficacy and effectiveness samples
differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials. J Clin
Psychiatry.
2010 Nov;71(11):1425-33.

Seemüller F, Schennach-Wolff R, Obermeier M, Henkel V, Möller HJ, Riedel M. Does early improvement in major
depression protect against treatment emergent suicidal ideation? J Affect Disord. 2010 Jul;124(1-2):183-6.

Seemüller F, Riedel M, Obermeier M, Bauer M, Adli M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W,
Heuser I, Zeiler J, Gaebel W, Dichgans E, Bottländer R, Musil R, Möller HJ. Outcomes of 1014 naturalistically
treated inpatients with major depressive episode. Eur Neuropsychopharmacol. 2010 May;20(5):346-55.

Seemüller F, Riedel M, Dargel S, Djaja N, Schennach-Wolff R, Dittmann S, Möller HJ, Severus E. [Bipolar
depression. Spectrum of clinical pictures and differentiation from unipolar depression]. Nervenarzt. 2010
May;81(5):531-8. German.
Seemüller F, Riedel M, Obermeier M, Bauer M, Adli M, Mundt C, Holsboer F, Brieger P, Laux G, Bender W,
Heuser I, Zeiler J, Gaebel W, Jäger M, Henkel V & Möller HJ: The controversial link between antidepressants and
suicidality risks in adults: data from a large naturalistic sample of inpatients with major depressive episode. Int J
Neuropsychopharmacol.
2009 Mar;12(2):181-9.
Seemüller F, Riedel M, Wickelmaier F, Adli M, Mundt C, Marneros A, Laux G, Bender W, Heuser I, Zeiler J,
Gaebel W, Jäger M, Möller HJ & Henkel V. Atypical symptoms in hospitalised patients with major depressive
episode: frequency, clinical characteristics, and internal validity. J Affect Disord. 2008 Jun;108(3):271-8.


Seemüller F, Volkmer E, Vogel T, Hummel T, Krauseneck T, Riedel M, Padberg F. Quetiapine as treatment for
delirium during weaning from ventilation: a case report. J Clin Psychopharmacol. 2007 Oct;27(5):526-8.
Diebold J, Seemüller F, and Lohrs U: K-RAS Mutations in Ovarian and Extraovarian Lesions of Serous Tumors of
Borderline Malignancy. Lab Invest. 2003 Feb;83(2):251-8.

Source: http://www.psychiatrie-gap.de/fileadmin/psychiatrie-landsberg/files/PDFs/GAP/Publikationsverzeichnis_Seemueller_111213.pdf

Tosca lucie flore

Lucie TOSCA Laboratory address : UMR CNRS 8080 "Développement et Evolution" Université Paris-Sud IBAIC, Bât 444 91405 Orsay Cedex, FRANCE [email protected] Education and research experiment: 2007-2009 Post-Doctoral position - National Center of Scientific Research (CNRS), Laboratory of Developmental biology and Evolution, University Paris Sud, Orsay, France. Superviso

Exc_pressr_hr_us_t02.dotx

Exelon launches new brand strategy and logo following recent merger with Constellation CHICAGO (May 24, 2012) — Exelon Corporation today revealed its new brand strategy, including the new corporate vision and values that will guide the energy company going forward, as well as a new logo and visual identity, following Exelon’s recent merger with Constellation. “Together, Exelon and

Copyright © 2011-2018 Health Abstracts